Team

Convening the world’s leaders to unlock generative covalent chemistry.

Led by pioneers in covalent drug discovery, generative biology, chemoproteomics, and small molecule AI, we are tackling one of the grand challenges of medicine.

Get to know the leaders of our expedition.

Leadership

  • Dean Stamos, PhD

    Chief Scientific Officer, Proteomics & Chemistry | Co-Founder

  • Roli Khattri, PhD

    SVP, Head of Immunology

  • Dylan Mitchell, PhD

    Head of Proteomics

  • Chris Lepre, PhD

    Head of BioChem, Biophys, & Structural Bio

  • Yuta Naro, PhD

    Head of Bifunctional Discovery

  • Dongyu Sun, PhD

    Head of Chemical Sciences

  • Wei Lin, PhD

    Head of Formulations

Board & Advisors

  • Avak Kahvejian, PhD

    Board Member
    President, Flagship Labs
    General Partner, Flagship Pioneering

  • Geoff von Maltzahn, PhD

    Board Member
    CEO, Lila Sciences
    Co-Founder, Expedition Medicines
    General Partner, Flagship Pioneering

  • Mike Nally

    Board Member
    CEO, Generate Biomedicines
    CEO-Partner, Flagship Pioneering

  • Alec Reynolds

    Board Member
    President & CEO, Expedition Medicines
    Senior Partner, Flagship Pioneering

  • Gary Pisano, PhD

    Board Member
    Chief Strategist, Executive Partner, Flagship Pioneering

  • Rupert Vessey, PhD

    Board Member
    Chief Scientist, Executive Partner, Flagship Pioneering

  • Steve Gygi, PhD

    Advisor
    Professor, Harvard University

  • Chris Bishop, PhD

    Advisor
    Technical Fellow and Director
    Microsoft Research AI for Science

  • Joel Barrish, PhD

    Advisor
    Venture Partner
    RA Capital Ventures

  • Donald Payan, MD

    Advisor